Trifluoroacetic acid → HCID 22629192, compound

HRID 965371Notes

Reaction equation

HRID 965371 reaction equation
C(OC([N:8]1[CH2:13][CH2:12][C:11](=[O:14])[CH:10]([N:15]2[C:20](=[O:21])[CH:19]=[CH:18][C:17]([C:22]3[C:23]([C:31]4[CH:36]=[CH:35][CH:34]=[CH:33][CH:32]=4)=[N:24][N:25]4[CH:30]=[CH:29][CH:28]=[CH:27][C:26]=34)=[N:16]2)[CH2:9]1)=O)(C)(C)C.FC(F)(F)C(O)=O>ClCCl.CO>[O:14]=[C:11]1[CH2:12][CH2:13][NH:8][CH2:9][CH:10]1[N:15]1[C:20](=[O:21])[CH:19]=[CH:18][C:17]([C:22]2[C:23]([C:31]3[CH:36]=[CH:35][CH:34]=[CH:33][CH:32]=3)=[N:24][N:25]3[CH:30]=[CH:29][CH:28]=[CH:27][C:26]=23)=[N:16]1

Participants

5

Procedure

To a solution of 3-[2-(1-tert-butoxycarbonyl-4-oxopiperidin-3-yl)-3-oxo-2,3-dihydropyridazin-6-yl]-2-phenylpyrazolo[1,5-a]pyridine (500 mg) in dichloromethane (10 ml) was added trifluoroacetic acid (5 ml) at room temperature, and stirred for 2 hours. Solvent was evaporated and removed by toluene azeotrope to give residue, which was chromatographed on silica gel eluting in turn with 5% and 10% methanol in dichloromethane. Fractions containing desired product were collected and concentrated in vacuo to give residue, which was dissolved in methanol and passed through Amberlite IRA-910 (10 ml) eluting with methanol. Solvent was removed under reduced pressure to give 3-[2-(4-oxopiperidin-3-yl)-3-oxo-2,3-dihydropyridazin-6-yl]-2-phenylpyrazolo[1,5-a]pyridine (0.3 g).

Workup

  1. customSolvent was evaporated
  2. customremoved by toluene azeotrope
  3. customto give residue, which
  4. customwas chromatographed on silica gel eluting in turn with 5% and 10% methanol in dichloromethane
  5. additionFractions containing desired product
  6. customwere collected
  7. concentrationconcentrated in vacuo
  8. customto give residue, which
  9. washeluting with methanol
  10. customSolvent was removed under reduced pressure

Sources & evidence

ORD record
ord-94302783c0ce43b082bd644e55d14f24
Source dataset
uspto-grants-1998_06
Patent number
US05773530

Reaction notes

Loading…